88:
to retain those with inflammatory arthritis by preventing work-related injuries and by making necessary accommodations in the workplace. A 2014 Cochrane review found low-quality evidence that work focused interventions, including counseling, education, advocacy, and occupational medicine consultations, were effective in retaining workers with inflammatory arthritis.
87:
Inflammatory arthritis can be disabling to the point where people with the diseases can lose their jobs, which can cause psychological distress. Because it is typically progressive, those who lose their jobs are unlikely to re-enter the workforce after leaving due to their diagnosis. Programs now aim
58:
Symptoms of inflammatory arthritis include stiffness, pain, and swelling of the joints, restricted motions, and reduced physical strength. Other symptoms may include systemic complaints including fatigue.
150:
134:
35:
43:
47:
31:
108:
are the most common subtypes of inflammatory arthritis. The diseases occur most commonly in the 30-40 age group.
101:
76:
27:
23:
173:"Non-pharmacological interventions for preventing job loss in workers with inflammatory arthritis"
228:
144:
204:
130:
105:
194:
184:
100:
of inflammatory arthritis is approximately 3%. Rheumatoid arthritis, psoriatic arthritis,
199:
172:
222:
189:
171:
Hoving JL, Lacaille D, Urquhart DM, Hannu TJ, Sluiter JK, Frings-Dresen MH (2014).
39:
97:
68:
208:
72:
71:
vary by subtype, though they may include drugs like
129:. London: Pharmaceutical Press. p. 102.
75:(disease-modifying anti-rheumatic drugs) and
8:
149:: CS1 maint: multiple names: authors list (
177:The Cochrane Database of Systematic Reviews
166:
164:
162:
160:
198:
188:
125:Greenstein, Ben Greenstein, Adam (2007).
117:
22:is a group of diseases which includes:
142:
7:
14:
190:10.1002/14651858.CD010208.pub2
1:
127:Concise clinical pharmacology
44:juvenile idiopathic arthritis
67:Treatments for inflammatory
48:systemic lupus erythematosus
36:adult-onset Still's disease
245:
32:inflammatory bowel disease
104:, and undifferentiated
102:ankylosing spondylitis
20:Inflammatory arthritis
77:tumor necrosis factor
28:psoriatic arthropathy
24:rheumatoid arthritis
54:Signs and symptoms
106:spondyloarthritis
16:Group of diseases
236:
213:
212:
202:
192:
183:(11): CD010208.
168:
155:
154:
148:
140:
122:
244:
243:
239:
238:
237:
235:
234:
233:
219:
218:
217:
216:
170:
169:
158:
141:
137:
124:
123:
119:
114:
94:
85:
65:
56:
17:
12:
11:
5:
242:
240:
232:
231:
221:
220:
215:
214:
156:
136:978-0853695769
135:
116:
115:
113:
110:
96:The worldwide
93:
90:
84:
81:
64:
61:
55:
52:
15:
13:
10:
9:
6:
4:
3:
2:
241:
230:
227:
226:
224:
210:
206:
201:
196:
191:
186:
182:
178:
174:
167:
165:
163:
161:
157:
152:
146:
138:
132:
128:
121:
118:
111:
109:
107:
103:
99:
91:
89:
82:
80:
78:
74:
70:
62:
60:
53:
51:
49:
45:
41:
37:
33:
29:
25:
21:
180:
176:
126:
120:
95:
92:Epidemiology
86:
79:inhibitors.
66:
57:
19:
18:
40:scleroderma
112:References
98:prevalence
63:Management
229:Arthritis
145:cite book
83:Prognosis
69:arthritis
223:Category
209:25375291
200:11287239
50:(SLE).
207:
197:
133:
73:DMARDs
46:, and
205:PMID
151:link
131:ISBN
195:PMC
185:doi
225::
203:.
193:.
181:11
179:.
175:.
159:^
147:}}
143:{{
42:,
38:,
34:,
30:,
26:,
211:.
187::
153:)
139:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.